Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Stage-regulated GFP Expression in Trypanosoma cruzi: applications from host-parasite interactions to drug screening.

Kessler RL, Gradia DF, Pontello Rampazzo Rde C, Lourenço ÉE, Fidêncio NJ, Manhaes L, Probst CM, Ávila AR, Fragoso SP.

PLoS One. 2013 Jun 20;8(6):e67441. doi: 10.1371/journal.pone.0067441. Print 2013.

2.

Cell culture and animal infection with distinct Trypanosoma cruzi strains expressing red and green fluorescent proteins.

Pires SF, DaRocha WD, Freitas JM, Oliveira LA, Kitten GT, Machado CR, Pena SD, Chiari E, Macedo AM, Teixeira SM.

Int J Parasitol. 2008 Mar;38(3-4):289-97. Epub 2007 Sep 26.

PMID:
17967460
3.

Natural sesquiterpene lactones induce programmed cell death in Trypanosoma cruzi: a new therapeutic target?

Jimenez V, Kemmerling U, Paredes R, Maya JD, Sosa MA, Galanti N.

Phytomedicine. 2014 Sep 25;21(11):1411-8. doi: 10.1016/j.phymed.2014.06.005. Epub 2014 Jul 8.

PMID:
25022207
4.

Trypanosoma cruzi: in vitro activity of Epoxy-alpha-Lap, a derivative of alpha-lapachone, on trypomastigote and amastigote forms.

Bourguignon SC, Castro HC, Santos DO, Alves CR, Ferreira VF, Gama IL, Silva FC, Seguins WS, Pinho RT.

Exp Parasitol. 2009 Jun;122(2):91-6. doi: 10.1016/j.exppara.2009.03.002. Epub 2009 Mar 11.

PMID:
19285074
5.

In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.

Becerra MC, Guiñazú N, Hergert LY, Pellegrini A, Mazzieri MR, Gea S, Albesa I.

Exp Parasitol. 2012 May;131(1):57-62. doi: 10.1016/j.exppara.2012.02.028. Epub 2012 Mar 8.

PMID:
22425748
6.

Laboratory techniques to obtain different forms of Trypanosoma cruzi: applications to wild-type and genetically modified parasites.

de Cámara Mde L, Bouvier LA, Miranda MR, Reigada C, Pereira CA.

Folia Parasitol (Praha). 2013 Nov;60(5):406-10.

PMID:
24471281
7.

Trypanosoma cruzi: Biological characterization of lineages I and II supports the predominance of lineage I in Colombia.

Mejía-Jaramillo AM, Peña VH, Triana-Chávez O.

Exp Parasitol. 2009 Jan;121(1):83-91. doi: 10.1016/j.exppara.2008.10.002. Epub 2008 Oct 8.

PMID:
18950627
8.

Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele.

Allaoui A, François C, Zemzoumi K, Guilvard E, Ouaissi A.

Mol Microbiol. 1999 Jun;32(6):1273-86.

9.

In vitro activity of Etanidazole against the protozoan parasite Trypanosoma cruzi.

Petray PB, Morilla MJ, Corral RS, Romero EL.

Mem Inst Oswaldo Cruz. 2004 Mar;99(2):233-5. Epub 2004 Jun 24.

10.

Host cell actin remodeling in response to Trypanosoma cruzi: trypomastigote versus amastigote entry.

Mortara RA, Andreoli WK, Fernandes MC, da Silva CV, Fernandes AB, L'Abbate C, da Silva S.

Subcell Biochem. 2008;47:101-9. Review.

PMID:
18512345
11.

Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.

Sangenito LS, Menna-Barreto RF, D Avila-Levy CM, Santos AL, Branquinha MH.

PLoS One. 2014 Dec 2;9(12):e113957. doi: 10.1371/journal.pone.0113957. eCollection 2014.

12.

Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi.

Faundez M, Pino L, Letelier P, Ortiz C, López R, Seguel C, Ferreira J, Pavani M, Morello A, Maya JD.

Antimicrob Agents Chemother. 2005 Jan;49(1):126-30.

13.

Anti-Trypanosoma cruzi effects of cyclosporin A derivatives: possible role of a P-glycoprotein and parasite cyclophilins.

Búa J, Fichera LE, Fuchs AG, Potenza M, Dubin M, Wenger RO, Moretti G, Scabone CM, Ruiz AM.

Parasitology. 2008 Feb;135(2):217-28. Epub 2007 Oct 9.

PMID:
17922928
14.

Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties.

Revollo S, Oury B, Laurent JP, Barnabé C, Quesney V, Carrière V, Noël S, Tibayrenc M.

Exp Parasitol. 1998 May;89(1):30-9.

PMID:
9603486
15.

Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi.

Garzoni LR, Caldera A, Meirelles Mde N, de Castro SL, Docampo R, Meints GA, Oldfield E, Urbina JA.

Int J Antimicrob Agents. 2004 Mar;23(3):273-85.

PMID:
15164969
16.

Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.

Urbina JA, Lazardi K, Marchan E, Visbal G, Aguirre T, Piras MM, Piras R, Maldonado RA, Payares G, de Souza W.

Antimicrob Agents Chemother. 1993 Mar;37(3):580-91.

17.

Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.

Ribeiro TS, Freire-de-Lima L, Previato JO, Mendonça-Previato L, Heise N, de Lima ME.

Bioorg Med Chem Lett. 2004 Jul 5;14(13):3555-8.

PMID:
15177472
18.
19.

Automated high-content assay for compounds selectively toxic to Trypanosoma cruzi in a myoblastic cell line.

Alonso-Padilla J, Cotillo I, Presa JL, Cantizani J, Peña I, Bardera AI, Martín JJ, Rodriguez A.

PLoS Negl Trop Dis. 2015 Jan 23;9(1):e0003493. doi: 10.1371/journal.pntd.0003493. eCollection 2015 Jan.

20.

Expression of fluorescent genes in Trypanosoma cruzi and Trypanosoma rangeli (Kinetoplastida: Trypanosomatidae): its application to parasite-vector biology.

Guevara P, Dias M, Rojas A, Crisante G, Abreu-Blanco MT, Umezawa E, Vazquez M, Levin M, Añez N, Ramirez JL.

J Med Entomol. 2005 Jan;42(1):48-56.

PMID:
15691008

Supplemental Content

Support Center